Literature DB >> 12508161

Induction of apoptosis of human brain microvascular endothelial cells by shiga toxin 1.

Zuhal Ergonul1, Alisa K Hughes, Donald E Kohan.   

Abstract

Brain injury is the most frequent cause of mortality among patients with the hemolytic-uremic syndrome. Human brain endothelial cells (HBECs) are resistant to Escherichia coli-derived Shiga toxin (Stx); however, inflammatory cytokines markedly increase HBEC sensitivity to Stx cytotoxicity. HBECs were exposed to tumor necrosis factor (TNF)-alpha, with and without Stx-1, and cell survival, (125)I-Stx1 binding, globotriaosylceramide content, cell necrosis, and cell apoptosis levels were determined. TNF greatly increased Stx-1 cytotoxicity, primarily through induction of apoptosis, in HBEC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12508161     DOI: 10.1086/345861

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

1.  Intestinal damage in enterohemorrhagic Escherichia coli infection.

Authors:  Zivile D Békássy; Carla Calderon Toledo; Gustav Leoj; Anncharlotte Kristoffersson; Shana R Leopold; Maria-Thereza Perez; Diana Karpman
Journal:  Pediatr Nephrol       Date:  2010-09-01       Impact factor: 3.714

Review 2.  Shiga toxin pathogenesis: kidney complications and renal failure.

Authors:  Tom G Obrig; Diana Karpman
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

3.  Metabolomic analysis of Shiga toxin 2a-induced injury in conditionally immortalized glomerular endothelial cells.

Authors:  Christian Patry; Kathrin Plotnicki; Christian Betzen; Alba Perez Ortiz; Kirk L Pappan; Simon C Satchell; Peter W Mathieson; Martina Bielaszewska; Helge Karch; Burkhard Tönshoff; Neysan Rafat
Journal:  Metabolomics       Date:  2019-10-01       Impact factor: 4.290

4.  Shiga toxin binding to isolated porcine tissues and peripheral blood leukocytes.

Authors:  Kellie R K Winter; William C Stoffregen; Evelyn A Dean-Nystrom
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

Review 5.  Facing glycosphingolipid-Shiga toxin interaction: dire straits for endothelial cells of the human vasculature.

Authors:  Andreas Bauwens; Josefine Betz; Iris Meisen; Björn Kemper; Helge Karch; Johannes Müthing
Journal:  Cell Mol Life Sci       Date:  2012-07-06       Impact factor: 9.261

6.  Distinct physiologic and inflammatory responses elicited in baboons after challenge with Shiga toxin type 1 or 2 from enterohemorrhagic Escherichia coli.

Authors:  D J Stearns-Kurosawa; Valta Collins; Scott Freeman; Vernon L Tesh; Shinichiro Kurosawa
Journal:  Infect Immun       Date:  2010-03-22       Impact factor: 3.441

Review 7.  Renal and neurological involvement in typical Shiga toxin-associated HUS.

Authors:  Howard Trachtman; Catherine Austin; Maria Lewinski; Rolf A K Stahl
Journal:  Nat Rev Nephrol       Date:  2012-09-18       Impact factor: 28.314

8.  Glycosphingolipids in vascular endothelial cells: relationship of heterogeneity in Gb3Cer/CD77 receptor expression with differential Shiga toxin 1 cytotoxicity.

Authors:  Christian H Schweppe; Martina Bielaszewska; Gottfried Pohlentz; Alexander W Friedrich; Heino Büntemeyer; M Alexander Schmidt; Kwang S Kim; Jasna Peter-Katalinić; Helge Karch; Johannes Müthing
Journal:  Glycoconj J       Date:  2008-01-05       Impact factor: 2.916

9.  Shiga toxin 2 causes apoptosis in human brain microvascular endothelial cells via C/EBP homologous protein.

Authors:  Jun Fujii; Katie Wood; Fumiko Matsuda; Benedito A Carneiro-Filho; Keilo H Schlegel; Takashi Yutsudo; Beth Binnington-Boyd; Clifford A Lingwood; Fumiko Obata; Kwang S Kim; Shin-ichi Yoshida; Tom Obrig
Journal:  Infect Immun       Date:  2008-06-09       Impact factor: 3.441

10.  Shiga toxin 2 affects the central nervous system through receptor globotriaosylceramide localized to neurons.

Authors:  Fumiko Obata; Koujiro Tohyama; Adrian D Bonev; Glynis L Kolling; Tiffany R Keepers; Lisa K Gross; Mark T Nelson; Shigehiro Sato; Tom G Obrig
Journal:  J Infect Dis       Date:  2008-11-01       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.